Afya (AFYA) Cash & Equivalents (2017 - 2026)

Afya has disclosed Cash & Equivalents across 10 years of filings, most recently posting $213.8 million for Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $213.8 million, up 37.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $213.8 million (up 37.54% YoY), and the FY2025 annual result was $208.7 million, up 33.16% from the prior year.
• Cash & Equivalents came in at $213.8 million for Q1 2026 at Afya, up from $208.7 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $224.0 million in Q3 2023 to a low of $99.7 million in Q3 2024.
• The 5-year median for Cash & Equivalents is $156.8 million (2024), against an average of $166.9 million.
• Across the five-year window, Cash & Equivalents plunged 55.48% in 2024 and surged 67.65% in 2025, its largest moves.
• Afya's Cash & Equivalents stood at $142.3 million in 2022, then surged by 55.17% to $220.8 million in 2023, then fell by 29.0% to $156.8 million in 2024, then jumped by 33.16% to $208.7 million in 2025, then gained by 2.44% to $213.8 million in 2026.
• The last three Cash & Equivalents figures came in at $213.8 million (Q1 2026), $208.7 million (Q4 2025), and $167.2 million (Q3 2025), per Business Quant data.